The U.S. subsidiary of Germany's Bayer AG and Roche Holding Ltd., Basel, Switzerland, will form a joint venture to market over-the-counter drugs in the U.S. Except for Bayer aspirin, the joint venture combines the companies' OTC businesses in analgesics and women's health. Roche's Aleve analgesic and Femstat 3 vaginal yeast infection treatment and Bayer's Actron and Vanquish analgesics, Midol menstrual pain reliever and Mycelex-7 vaginal yeast infection treatment will be included. The companies are still deciding which ad agencies will handle the joint efforts. Leo Burnett
handles Femstat 3, DMB&B handles Aleve, Euro RSCG Tatham handles Mycelex-7 and Midol, and BBDO
currently handles Actron and Vanquish.